My Account |

“Human Urokinase (uPA) Activity Assay Kit (Indirect Assay)” has been added to your cart. View cart

Human Urokinase (uPA) ELISA Kit

Name: Human Urokinase (uPA) ELISA Kit
Brand: AssayMax&trade; ELISA Kits
SKU: EU1001-1
Availability: InStock

$407.00

Catalog Number: EU1001-1

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Catalog Number. EU1001-1 Categories: ELISA Kits, Kits, Sandwich ELISA Tag: Urokinase Brand: AssayMax™ ELISA Kits

Additional information

Format	Sandwich ELISA
Entrez Gene	5328
Components	Biotinylated Human uPA Antibody, Chromogen Substrate (1x), Human uPA Microplate, Human uPA Standard, MIX Diluent Concentrate (10x), Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)
TIme	4 hours
Sensitivity	45 pg/ml
Range	0.125 – 4 ng/ml
Samples Type	Cell Culture Supernatants, Cell Lysates, Milk, Plasma, Serum, Tissue Extract, Urine
Associated Disease	Cancer
Species	Human
UniProt	P00749
Storage	Refer to component labels for details
Plex	1
Usage	For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications

"* Rashad AE et al. (2015) Synthesis and anticancer evaluation of some fused pyrazolopyrimidines and their S-acyclic nucleosides. Der Pharma Chemica. 7(5):243-250
"* Rashad MM et al. (2014) Production, characterization and anticancer activity of Candida bombicola sophorolipids by means of solid state fermentation of sunflower oil cake and soybean oil. Grasas Aceites 65 (2), e017. ISSN-L: 0017-3495
"* Mori Y et al. (2014) MUC1 Protein Induces Urokinase-type Plasminogen Activator (uPA) by Forming a Complex with NF-kappaB p65 Transcription Factor and Binding to the uPA Promoter, Leading to Enhanced Invasiveness of Cancer Cells. J Biol Chem. 289(51):35193-35204
"* Mahmoud AE and Ali MM (2014) Fermented Pomegranate (Punica granatum) Peel Extract as a Novel Anticancer Agent Targeting Angiogenesis and Metastasis. International Journal of toxicological and pharmacological research. 6(4):60-66
"* Madkour HMF et al. (2014) 2-{[3-Cyano-4-(furan-2-yl)-6-(naphthalen-1-yl)pyridin-2-yl]oxy}acetohydrazide as a synthon for Potent Anticancer Agents. International Journal of Advanced Scientific and Technical Research. 2 (4):March-April 2014.
"* Wyrebska A et al. (2013) Anticancer Activity of New Synthetic alpha-Methylene-delta-Lactones on Two Breast Cancer Cell Lines. Basic Clin Pharmacol Toxicol. 113(6):391-400
"* Vieira ML et al. (2013) Interaction of Leptospira interrogans with Human Proteolytic Systems Enhances Dissemination through Endothelial Cells and Protease Levels. Infect Immun. 81(5):1764-74. doi: 10.1128/IAI.00020-13. Epub 2013 Mar 11
"* Takabayashi T et al. (2013) Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression. Am J Respir Crit Care Med. 187(1):49-57.
"* Shamroukh AH (2013) Anticancer evaluation of some newly synthesized N-nicotinonitrile derivative. Eur J Med Chem. 69:521-526
"* Lugano R (2013) Low density lipoproteins, vascular smooth muscle cell function and vascular remodeling. Pompeu Fabra University.
"* Flores JM (2013) Artificial neural network-based serum biomarkers analysis improves sensitivity in the diagnosis of lung cancer. IFMBE Proceedings. 33:882-885.
"* Wyrebska A et al. (2012) Comparison of Anti-Invasive Activity of Parthenolide and 3-Isopropyl-2-Methyl-4-Methyleneisoxazolidin-5-One (MZ-6)--A New Compound with alpha-Methylene-gamma-Lactone Motif-on Two Breast Cancer Cell Lines. Chem Biol Drug Des. 79(1):112-120
"* Vieira ML et al. (2012) The interaction of Leptospira interrogans with juman proteolytic system enhaces dissemination through endothelial cells and the levels of plasminogen activators and matrix metalloprotease-9. University of Sao Paulo.
"* Qi J et al. (2012) A novel fibrinogenase from Agkistrodon acutus venom protects against DIC via direct degradation of thrombosis and activation of protein C. Biochem Pharmacol. 84(7):905-13.
"* Omar MA et al. (2012) Synthesis and docking studies of novel antitumor benzimidazoles. Bioorganic & Medicinal Chemistry 20(24):6989-7001.
"* Gach K et al. (2012) The influence of opioid peptides on matrix metalloproteinase-9 and urokinase plasminogen activator expression in three cancer cell lines. Mol Biol (Mosk). 46(6):894-9
"* Ferro M et al. (2012) PLASMATIC SIL 6R/IL-6 RATIO AS A POTENTIAL PREDICTOR OF HIGH GLEASON SUM AT RADICAL PROSTATECTOMY. ANTICANCER RESEARCH 32: 1843-1966
"* Sutoh T et al. (2010) Nafamostat Mesilate (FUT-175) Inhibits Cell Growth and Invasion of Malignant Pleural Mesothelioma Cell Line, MSTO-211H. Hirosaki Med. J. 61:19-25
"* Rasheed SA et al. (2010) First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int J Cancer. 127(6):1475-1485.
"* Grzmil M (2010) An oncogenic role of eIF3e/INT6 in human breast cancer. Oncogene. 29(28):4080-4089
"* Okumura S et al. (2009) Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: Preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells. Clin Immunol. 130(2):175-185
"* Gach K et al. (2009) The Influence of Opioids on Urokinase Plasminogen Activator on Protein and mRNA Level in MCF-7 Breast Cancer Cell Line. Chem Biol Drug Des. 74(4): 390-396.
"* Ekmekci OB et al. (2009) Effects of rhG-CSF Plus Dexamethasone on Hemostatic Parameters in Healthy Granulocyte Donors: Role of u-PA and Nitric Oxide. Clin. Appl. Thromb. Hemost. 15(6):689-694
"* Ogura Y et al. (2008) Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction. Br J Dermatol. 159(1):49-60
"* Yoshida C et al. (2007) Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells. Blood Coagul Fibrinolysis. 18(5):425-433
"* Yang CC et al. (2007) In vitro regulation of adipogenesis: tunable engineered tissues. J Tissue Eng Regen Med. 1(2):146-153
"* Cederqvist K et al. (2006) High Concentrations of Plasminogen Activator Inhibitor-1 in Lungs of Preterm Infants With Respiratory Distress Syndrome. Pediatrics. 117(4):1226-1234
"* Yamaguchi Y et al. (2005) Possible Involvement of Urokinase-Type Plasminogen Activator Release From Human Peripheral Blood Lymphocytes in the Pathophysiology of Chronic Allograft Nephropathy. Transplant Proc. 37(10):4276-4281
"* Nomuraa S et al. (2005) HMG-CoA Reductase Inhibitors Reduce Matrix Metalloproteinase-9 Activity in Human Varicose Veins. Eur Surg Res. 37(6):370-378
"* Yamaguchi Y et al. (2004) Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP). Am J Physiol Endocrinol Metab 287(5): E970-E976
"* Uchima Y et al. (2004) Inhibition and Mechanism of Action of a Protease Inhibitor in Human Pancreatic Cancer Cells.??Pancreas 29(2):123-131
"* Ueshima S et al. (2003) Suppression of the release of type-1 plasminogen activator inhibitor from human vascular endothelial cells by Hawaii deep sea water. Pathophysiology 9:103-109
"* Oka N et al. (2003) Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion. Eur Urol. 44(6):737-741
"* Fujiuchi Y et al. (2003) Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncol. Rep. 10(4):1001-1006

Human Urokinase (uPA) ELISA Kit

Additional information

Documentation

Publications

Related products

Human Urokinase (uPA) Activity Assay Kit (Direct Assay)

Human Urokinase (uPA) Activity Assay Kit (Indirect Assay)